Brief: Oncolytics Biotech Announces Presentation Of Preclinical Data Demonstrating Synergistic Anti-Leukemic Effects Of Pelareorep Combined With Azacitidine
15/12/2021 14:17
Dec 15 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH ANNOUNCES PRESENTATION OF PRECLINICAL
DATA
DEMONSTRATING SYNERGISTIC ANTI-LEUKEMIC EFFECTS OF PELAREOREP
COMBINED WITH AZACITIDINE AT 2021 AMERICAN SOCIETY OF HEMATOLOGY
ANNUAL MEETING
Source text for Eikon: ID:nPn51CxL2a
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer